STO:CEVI

CellaVision AB (publ) · STO · Healthcare · SEK · FY for 2025

Figures on this page computed 2026-11-08 12:25 UTC

Last close

n/aSEK

Market data

31.0xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
SEK
- computed
- Computed from the filing for 2025
22.0%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
20.2%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
23.9%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
0.03Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
1.3%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
SEK
- computed

Price is the furthest below its sector's middle: 0.25 against 0.36 on the market's range.

All from 100

lens 2 of 9

Sales

286

2016-12-31 to 2025-12-31100 at the start286

Sales: 100.00 on 2016-12-31 to 286.36 on 2025-12-31, up 186%.

Profit

256

2016-12-31 to 2025-12-31100 at the start256

Profit: 100.00 on 2016-12-31 to 255.98 on 2025-12-31, up 156%.

Shares in issue

100.0

2016-12-31 to 2025-12-31100 at the start100.0

Shares in issue: 100.00 on 2016-12-31 to 100.00 on 2025-12-31, down 0%.

Sales is at 286, Profit is at 256, Shares in issue is at 100, against 100 in 2016.

Sales is at 286, Profit is at 256, Shares in issue is at 100, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 100286
Source
computed
Statement
income
Fiscal year
2025
Reported in
SEK
Profit, where the first year is 100256
Source
computed
Statement
income
Fiscal year
2025
Reported in
SEK
Shares in issue, where the first year is 100100
Source
computed
Statement
income
Fiscal year
2025
Reported in
SEK